Vancouver, British Columbia–(Newsfile Corp. – April 24, 2017) – True Leaf Medicine Inc. (True Leaf), a division of True Leaf Medicine International Ltd. (CSE: MJ) (FSE: TLA), has engaged a number of cannabis experts to guide the company through the final stage in Health Canada’s review of its application for a license to produce marijuana in Canada.

Experts from industry-leading PipeDreemz Inc., Protect-IP Global Solutions Inc., Eurofins Scientific, and Ample Organics will be working with True Leaf over the next few weeks to prepare a review package for submission to Health Canada under the Access to Cannabis for Medical Purposes Regulations (Cannabis Act) application process.

Health Canada recently upgraded the Marihuana for Medical Purposes Regulations (MMPR) application process to the Cannabis Act licensing program, so the experts will be working with True Leaf to update its original MMPR application to ensure True Leaf meets or exceeds the new compliance measures.
Read more